CVE-2026-52866

MEDIUM 6.5

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization

CVSS Score

6.5

EPSS Score

0.0%

EPSS Percentile

0th

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

CWE	CWE-862
Vendor	apollo pharmacy
Product	blood glucose monitoring system (model no. apg-01 bt)
Published	Jun 18, 2026

Stay Ahead of the Next One

Get instant alerts for apollo pharmacy blood glucose monitoring system (model no. apg-01 bt)

Be the first to know when new medium vulnerabilities affecting apollo pharmacy blood glucose monitoring system (model no. apg-01 bt) are published — delivered to Slack, Telegram or Discord.

Get Free Alerts → Free · No credit card · 60 sec setup

CVSS v3 Breakdown

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Attack Vector

Adjacent

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

None

Integrity

None

Availability

High

Affected Versions

Apollo Pharmacy / Blood Glucose Monitoring System (Model No. APG-01 BT)

0x0110_v1.1.0

References

NVD ↗ CVE.org ↗ EPSS Data ↗

apollopharmacy.in: https://www.apollopharmacy.in/contact-us cisa.gov: https://www.cisa.gov/news-events/news/understanding-bluetooth-technology cisa.gov: https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01 github.com: https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json

Credits

Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA.